Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$8.7 - $15.02 $521,999 - $901,200
60,000 New
60,000 $874,000
Q2 2021

Aug 16, 2021

SELL
$14.25 - $30.93 $87,124 - $189,106
-6,114 Reduced 9.25%
60,000 $1.44 Million
Q2 2020

Aug 14, 2020

SELL
$4.42 - $11.04 $25,096 - $62,685
-5,678 Reduced 7.91%
66,114 $458,000
Q4 2019

Feb 14, 2020

SELL
$9.47 - $16.71 $43,751 - $77,200
-4,620 Reduced 6.05%
71,792 $764,000
Q3 2018

Nov 14, 2018

SELL
$20.96 - $30.77 $61,308 - $90,002
-2,925 Reduced 3.69%
76,412 $2.2 Million
Q2 2018

Aug 14, 2018

BUY
$16.13 - $26.99 $1.07 Million - $1.78 Million
66,114 Added 499.99%
79,337 $1.97 Million
Q1 2018

May 14, 2018

BUY
$13.55 - $21.3 $179,171 - $281,649
13,223 New
13,223 $218,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $196M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Punch & Associates Investment Management, Inc. Portfolio

Follow Punch & Associates Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Punch & Associates Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Punch & Associates Investment Management, Inc. with notifications on news.